Replimune stock soars on FDA priority review for melanoma treatment
Investing.com — Shares of Replimune Group, Inc. (NASDAQ: NASDAQ:REPL) surged 17% following the announcement that the U.S. Food and Drug Administration (FDA)
Investing.com — Shares of Replimune Group, Inc. (NASDAQ: NASDAQ:REPL) surged 17% following the announcement that the U.S. Food and Drug Administration (FDA)
Investing.com — President Trump is preparing to disclose a significant private sector commitment to the development of artificial intelligence infrastructure in the
(Reuters) – Real estate investment trust (REIT) Prologis (NYSE:PLD) beat Wall Street expectations for fourth-quarter core funds from operations (FFO),
Investing.com — Shares of aerospace and rocket technology companies saw significant gains in today’s trading session after President Trump announced plans to
By Foo Yun Chee BRUSSELS (Reuters) -U.S.-based International Paper is set to get EU approval for its 5.8 billion pound ($7.12 billion) purchase
Investing.com — Raymond James expects 2025 to be pivotal for generative AI commercialization and HardTech, given advancements in assistant-oriented use cases, autonomous vehicles,
Investing.com – Greece stocks were higher after the close on Tuesday, as gains in the Construction, Travel and Banking sectors led shares
Investing.com – Israel stocks were higher after the close on Tuesday, as gains in the Communication, Banking and Technology sectors led shares
Investing.com – Norway stocks were lower after the close on Tuesday, as losses in the Media, Transport and Diversified Financials sectors led
Investing.com — Jefferies downgraded Mondelez (NASDAQ:MDLZ) International from Buy to Hold, citing growing concerns over cocoa supply constraints that could weigh on the